Medical Library · Clinical Reference · Infectious Diseases

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Latest Developments in Hepatitis C1st EditionMobile App

Details the newest late-breaking approvals, recommendations, and key content on the treatment of hepatitis C

  • Editor(s) · John E. Bennett, MD, MACP, Raphael Dolin, MD and Martin J. Blaser, MD
  • Publisher · Elsevier, Inc
Works offlineOn your phone, even with no signal.
Linked libraryCross-linked to your other Skyscape titles, on the device.

About this title

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Latest Developments in Hepatitis C with accompanying Clinics Review Articles details the newest late-breaking approvals, recommendations, and key content on the treatment of hepatitis C in a convenient digital format. Brought to you by the expert editor team from Principles and Practice of Infectious Diseases, it provides the most current research and findings related to newly approved antivirals, guidelines for treatments, and clinical experiences with new HCV therapeutic regimens. In addition to this extended content, you'll also receive two accompanying Clinics Review Articles for further information on the management of the virus in women and patients with chronic liver disease.

Key Features
  • Includes information on the approval of six new antivirals.
  • Highlights the January 2015 guidelines for treatment of the virus.
  • Provides detailed information on the pharmacology of new drugs used in treatment.
  • Features the latest research in understanding the pathogenesis of HCV.
  • Details clinical experiences with the new HCV therapeutic regimens and their application to specific patient populations.
  • Includes two Clinics Review Articles: Prevalence and Management of Chronic Hepatitis C Virus Infection in Women and Chronic Liver Disease in the Human Immunodeficiency Virus Patient.

Edition · 1st Edition

{mdbidhepc:3169}

Evidence-based and unbiased.

No one is sponsoring our content. No advertising, no sponsored answers — ever.